Cancer

Items 1821-1830 of 2148

per page
Set Descending Direction
  1. Purpuromycin
    CAS  53969-01-0
    AG-CN2-0317
    AG-CN2-0317-M0055 mg
    CHF 200.00
    AG-CN2-0317-M02525 mg
    CHF 700.00
    Purpuromycin
  2. Purvalanol A
    CAS  212844-53-6
    AG-CR1-2903
    AG-CR1-2903-M0011 mg
    CHF 60.00
    AG-CR1-2903-M0055 mg
    CHF 120.00
    AG-CR1-2903-M02525 mg
    CHF 360.00
    Purvalanol A
  3. Purvalanol B
    CAS  212844-54-7
    SYN-1070
    SYN-1070-M0011 mg
    CHF 71.00
    SYN-1070-M0055 mg
    CHF 106.00
    SYN-1070-M01010 mg
    CHF 142.00
    SYN-1070-M05050 mg
    CHF 546.00
    SYN-1070-M100100 mg
    CHF 937.00
    Purvalanol B
  4. PX-12
    CAS  141400-58-0
    AG-CR1-3739
    AG-CR1-3739-M0011 mg
    CHF 30.00
    AG-CR1-3739-M0055 mg
    CHF 70.00
    AG-CR1-3739-M02525 mg
    CHF 210.00
    PX-12
  5. Pyranonigrin A
    CAS  773855-65-5
    AG-CN2-0156
    AG-CN2-0156-C250250 µg
    CHF 95.00
    AG-CN2-0156-M0011 mg
    CHF 250.00
    Pyranonigrin A
  6. Pyridoxatin
    CAS  135529-30-5
    AG-CN2-0123
    AG-CN2-0123-C250250 µg
    CHF 75.00
    AG-CN2-0123-M0011 mg
    CHF 220.00
    Pyridoxatin
  7. Pyripyropene A
    CAS  147444-03-9
    AG-CN2-0106
    AG-CN2-0106-C250250 µg
    CHF 190.00
    AG-CN2-0106-M0011 mg
    CHF 560.00
    Pyripyropene A
  8. Pyrrolcarbonyltaloside
    CAS  912539-02-7
    BVT-0095
    BVT-0095-M0011 mg
    CHF 95.00
    BVT-0095-M0055 mg
    CHF 335.00
    Pyrrolcarbonyltaloside
  9. Q-VD-OPh
    CAS  1135695-98-5 (anhydrous)
    AG-CP3-0006
    AG-CP3-0006-M0011 mg
    CHF 190.00
    AG-CP3-0006-30013 x 1 mg
    CHF 480.00
    AG-CP3-0006-M0055 mg
    CHF 750.00
    Q-VD-OPh
  10. Q-VE-OPh (Negative Control)
    AG-CP3-0007
    AG-CP3-0007-M0011 mg
    CHF 225.00
    Q-VE-OPh (Negative Control)

Items 1821-1830 of 2148

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.